Entry |
|
Name |
Taletrectinib (USAN/INN) |
Formula |
C23H24FN5O
|
Exact mass |
405.1965
|
Mol weight |
405.468
|
Structure |

|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
|
Remark |
|
Efficacy |
Antineoplastic, Tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03226 Taletrectinib
D12363 Taletrectinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
TRK family
NTRK
D12363 Taletrectinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03226 Taletrectinib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 C8x C 14.4900 -12.8100
2 C8y C 14.4900 -14.2100
3 N5x N 15.7024 -14.9100
4 N4y N 16.9149 -14.2100
5 C8y C 16.9149 -12.8100
6 C8x C 15.7024 -12.1100
7 C8y C 18.2464 -14.6426
8 C8x C 19.0693 -13.5100
9 N5x N 18.2464 -12.3774
10 C8y C 18.6775 -15.9694
11 C8x C 17.7511 -16.9985
12 C8x C 18.1838 -18.3299
13 C8y C 19.5533 -18.6209
14 C8x C 20.4797 -17.5918
15 C8x C 20.0470 -16.2603
16 O2a O 19.9834 -19.9446
17 C1b C 21.3218 -20.2293
18 C1c C 21.7570 -21.5695
19 C1a C 23.1368 -21.8632
20 N1a N 20.8305 -22.5980
21 N1b N 13.2776 -14.9100
22 C1c C 12.0821 -14.2196
23 C8y C 10.8947 -14.9051
24 C1a C 12.0820 -12.8103
25 C8x C 9.7035 -14.2171
26 C8y C 8.4910 -14.9169
27 C8x C 8.4908 -16.3169
28 C8x C 9.6820 -17.0049
29 C8x C 10.8945 -16.3051
30 X F 7.2599 -14.2059
BOND 33
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 2
11 7 10 1
12 10 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 14 15 2
17 10 15 1
18 13 16 1
19 16 17 1
20 17 18 1
21 18 19 1
22 18 20 1 #Up
23 2 21 1
24 21 22 1
25 22 23 1
26 22 24 1 #Up
27 23 25 2
28 25 26 1
29 26 27 2
30 27 28 1
31 28 29 2
32 23 29 1
33 26 30 1
|